New pharmaceutical projects strengthen cooperation in Central Asia

Continuous coordination for market development

The ACIR Southern Europe project office in Central Asia continues its active work with strategic regional partners. During recent meetings in Almaty, discussions focused on new pharmaceutical market trends, the expansion plans of European companies and new opportunities for Kazakh manufacturers and distributors.

The objective is to build long-term cooperation projects connecting European manufacturers with Central Asian companies through efficient logistics, financing and regulatory support.

Comprehensive support for European manufacturers

The meetings also reviewed the first deliveries of European pharmaceutical products that will soon enter the Kazakh market. These products are fully prepared to meet local regulatory and commercial requirements.

ACIR Southern Europe provides a complete market-entry ecosystem, including:

1. End-to-end export management.
2. Regulatory compliance across Central Asia.
3. Identification of distributors and business partners.
4. Logistics and trade financing solutions.
5. Marketing, positioning and commercial development.

Multilateral pharmaceutical and healthcare projects

Beyond product exports, ACIR Southern Europe promotes multilateral pharmaceutical and healthcare projects bringing together manufacturers, distributors, hospitals, healthcare institutions and investors from Europe and Central Asia.

This collaborative model accelerates technology transfer, encourages professional knowledge exchange and creates long-term partnerships that strengthen the pharmaceutical and healthcare sectors throughout Central Asia.